Objective-The angiopoietin (Ang)-Tie-2 system plays a critical role during fetal and adult angiogenesis. Herein, we explored the Tie-2 shedding-related molecular mechanisms and the pathophysiological significance. Methods and Results-By using a mouse hindlimb ischemia model, we observed dissociated expression between the full-length Tie-2 (fTie-2) protein and Tie-2 mRNA in thigh muscles 1 day after an ischemic operation, suggesting that fTie-2 expression was modified through the posttranscriptional regulation in vivo. A soluble form of Tie-2 produced in human umbilical vein endothelial cells was dramatically suppressed by treatment with siRNA-matrix metalloproteinase (MMP) 14 or tissue inhibitor of metalloproteinase 3, resulting in an increase in cellular fTie-2 and thereby enhancing Ang-1-dependent Akt phosphorylation and Akt-dependent endothelial functions, such as Ang-2 downregulation or an increase of endothelial viability. Phorbol-12-myristate-13 acetate (PMA) upregulates MMP-14 mRNA via protein kinase C-extracellular signal-regulated kinase pathways, and enhanced soluble Tie-2 production in an MMP-14dependent manner, resulting in a reduction of cellular fTie-2. In addition, the PMA-induced soluble Tie-2 was mediated by the protein kinase C-extracellular signal-regulated kinase signaling pathways. Finally, downregulation of tissue inhibitor of metalloproteinase 3 and upregulation of MMP-14 mRNA were confirmed in ischemic thigh muscles 1 day after the operation. Conclusion-An autocrine linkage between the endothelial protein kinase C-MMP-14 axis and Tie-2 shedding was shown to be a novel regulatory mechanism for the Ang-Tie-2 system and may play a role in modulating endothelial function during angiogenesis. (Arterioscler Thromb Vasc Biol. 2010;30:818-826.)
T he angiogenic process consists mainly of 3 steps (initiation, proliferation/extension, and maturation or regression) that are coordinately regulated by several angiogenesisrelated factors, [1] [2] [3] [4] [5] [6] and the angiopoietin (Ang)-Tie-2 system is thought to be one of the significant or critical systems in each phase. [7] [8] [9] [10] Traditional gene-targeting studies have revealed that Ang-1, an agonistic ligand for Tie-2, is essential for neovascularization with pericyte recruitment during fetal development, 9 as is Tie-2. 7, 8 In contrast, Ang-2 is generally believed to be an antagonistic ligand for Tie-2, and acts to block the interaction between Ang-1 and Tie-2. 10 Thus, a main regulatory mechanism of the system can be defined as a context-dependent blockade of Ang-1-Tie-2 interaction by Ang-2. Numerous studies have already suggested that the transition between vessel stabilization and destabilization is regulated by this system, and that this transition is important for angiogenic initiation. However, it remains uncertain whether the Ang-2-dependent regulation of Tie-2 signals is necessary during embryonic angiogenesis, because loss of Ang-2 function has almost no effect on fetal vascular development in Ang-2-deficient mice, 11 implying that an alternative mechanism to regulate Tie-2 signaling may compensate for loss of Ang-2 function. Despite advances in our understanding of the biological functions of this system, its detailed pathophysiological roles in adult angiogenesis remain unclear. One of the reasons for this is that there is no adult animal with a deficiency of each factor for use in in vivo pathological settings, because these animals die before adulthood. Another reason is that there are several inexplicable findings regarding the Ang-Tie-2 system, including the following: (1) Ang-1, an essential factor for vessel stabilization, can also induce vessel sprouting 12, 13 ; (2) Ang-2 possesses agonistic potential in vitro 14 ; and (3) excessive and constitutive Tie-2 signals induce venous malformation, char-acterized by a partial defect of smooth muscle coverage, although Tie-2 signals are essential for vessel stabilization. 15 These findings imply the complex and spatiotemporal roles of the Ang-Tie-2 system during fetal and adult angiogenesis.
Ectodomain shedding is one of the systems for regulating biological cellular functions, such as migration, proliferation, and apoptosis. 16, 17 The shedding action occurs via proteolytic activity on the cell surface. According to numerous reports, 16 ,17 a disintegrin and metalloproteinase (ADAM) family or membrane-type matrix metalloproteinase (MT-MMPs) family plays a central role in this biological phenomenon, and regulates cellular functions through the release of membraneassociated ligands or converted soluble receptors. In addition, ectodomain shedding occasionally causes reduced expression of the membrane protein on the cell surface 17 or induces such intracytoplasmic domain-mediated signal transductions as described by Bray. 18 Although Tie-2 is a membrane-anchored receptor and a soluble Tie-2 (sTie-2) mRNA splicing variant has never been reported, several previous studies have revealed that sTie-2 was detected in human serum or plasma, suggesting that shedding and release of endothelial Tie-2 occurs spontaneously in adult humans. In addition, it has been reported that the serum or plasma level of sTie-2 is higher in several clinical conditions, such as congestive heart failure, coronary artery disease, inflammation, and cancer. 19 -22 Moreover, only 2 studies 23, 24 have shown that endothelial cells (ECs) are able to produce sTie-2; this sTie-2 production was metalloproteinase dependent, and the produced sTie-2 was able to bind cognate ligands, thereby exerting an effect as a decoy receptor. 24 These data indicate that Tie-2 shedding may regulate the Ang-Tie-2 system. However, the biological significance of sTie-2 as a decoy receptor is inexplicable, because it can bind both Ang-1 and Ang-2, which exert the opposite action to the vascular system. Therefore, further investigation is necessary to clarify the biological and pathological significance of Tie-2 shedding.
Herein, we explored the relation between Tie-2 shedding and the Ang-Tie-2 regulation system, especially focusing on the identification of specific metalloproteinase to cause the shedding, and on the relationship between the shedding and the endothelial full-length Tie-2 (fTie-2) level.
Methods
Polymerase chain reaction (PCR) primers to amplify the nucleotide sequence coding ftie-2 or active MMP-14 (a-mmp-14) were purchased. A-mmp-14 was designed as prodomain-deficient mmp-14. Briefly, the human mmp-14 gene encoding signal peptide and prodomain were replaced by interleukin 6 signal sequences. The primer sequences are listed in the Supplemental Table ( available online at http://atvb.ahajournals.org). By using a cDNA template from human umbilical vein ECs (HUVECs), each PCR amplicon was obtained and inserted into pcDNA3.1(ϩ), a mammalian expression vector provided by a pcDNA3.1(ϩ) Thymidine adenine (TA) cloning kit (Invitrogen, Carlsbad, Calif), according to the manufacturer's instructions. Each inserted nucleotide sequence was examined using a CEQ 2000 Sequence Detection System (Beckman Coulter Inc, Fullerton, Calif), and complete matching compared with that reported in Gene Bank (accession No. for Tie-2: NM 182925; and for MMP-14: NM 004995) was confirmed. pcDNA3.1(ϩ)-firefly luciferase was kindly provided by Professor Y. Maehara of Kyushu University, Fukuoka, Japan. SiRNA for MMP-14 (siRNA-MMP-14 to 1 and siRNA-MMP-14 to 2) were purchased from Invitrogen. The sequence is as follows: siRNA-MMP-14 to 1: 5Ј-CCAGAAGCUGAAGGUAGAATT-3Ј; and siRNA-MMP-14 to 2: 5Ј-CAAAGUUCCCGUCACAGAUGUUGGG-3Ј. Control siRNA low GC Duplex (siRNA-control 1) and control siRNA high GC Duplex (siRNA-control 2) were purchased from Invitrogen, and used as a negative control. Plasmid or siRNA transfection was performed with lipofectamine LTX (Invitrogen) or oligofectamine (Invitrogen), respectively, according to the manufacturer's instructions.
Detailed information on the materials and methods, including the animals, reagents, cell culture, real-time reverse transcription-PCR, Western blot analysis, immunoprecipitation, ELISA, immunohistochemistry, cell viability assay, migration assay, and statistical analysis are described in the Supplemental Material (available online at http://atvb.ahajournals.org).
Results

Ischemia-Induced Posttranscriptional Regulation of fTie-2 in a Mouse Hindlimb Ischemia Model
A mouse limb salvage model was previously established. [3] [4] [5] [6] The blood flow in the hindlimb of this model is gradually restored after ischemic surgery without loss of the limb; thus, this model is available for studies examining time-dependent genes or the protein expression of angiogenesis-related factors in ischemic tissue. Through our investigation of the time-dependent expression of these factors, we obtained interesting results regarding Tie-2 expression in response to severe ischemia. In fact, although the level of Tie-2 mRNA, which was mainly expressed in ECs in the ischemic thigh muscular tissue (supplemental Figure I) , gradually increased in a time-dependent manner ( Figure 1A ), the level of fTie-2 was significantly reduced 1 day after ischemic surgery compared with that in the untreated controls ( Figure 1B) ; at that time, the Tie-2 mRNA expression was significantly upregulated, suggesting that the level of fTie-2 is modulated 
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by the context-dependent posttranscriptional regulation. Because no translational regulatory mechanisms of Tie-2 expression had been reported in any previous studies, we considered that the in vivo phenomenon was caused by posttranslational regulation, namely ectodomain shedding. Therefore, we investigated the detailed molecular mechanisms of Tie-2 shedding in vitro.
PMA-Induced sTie-2 Production in HUVECs Is Metalloproteinase Dependent
Consistent with a recent report, 24 sTie-2 with an approximately 75-kDa molecular weight was detected in the culture media from HUVECs (Figure 2A ). The sTie-2 production was drastically suppressed under treatment with GM6001, a metalloproteinase inhibitor with a wide spectrum of specificity, without any effect on Tie-2 gene expression ( Figure  2B -D), leading to upregulation of the cellular fTie-2 level ( Figure 2E ). The sTie-2 production was enhanced by PMA, an activator for ECs, without any effect on Tie-2 gene expression ( Figure 2F -H). Interestingly, the PMA-induced sTie-2 production led to downregulation of the cellular fTie-2 level ( Figure 2I ). These PMA-dependent phenomena were completely suppressed by GM6001 ( Figure 2G -I). These findings suggest that the production not only of spontaneous sTie-2 but also of the PMA-induced sTie-2 is dependent on endothelial metalloproteinase activity, and that Tie-2 shedding is linked with the endothelial fTie-2 level.
Tissue Inhibitor of Metalloproteinases 2 and 3, Not 1, Suppress sTie-2 Production in HUVECs
Next, we examined the effect of tissue inhibitor of metalloproteinase (TIMP) on sTie-2 production in HUVECs. The ELISA assay revealed that TIMP-1 did not affect the sTie-2 production ( Figure 3A ). In contrast, either TIMP-2 or TIMP-3 treatment significantly suppressed the sTie-2 production ( Figure 3A ). Based on these findings on the effects of each TIMP, we considered that the sTie-2 production was mediated by MT-MMPs, the activities of which were effectively inhibited by TIMP-2 or TIMP-3 but not by TIMP-1. 25 Interestingly, in our in vitro experiment with an exogenous fTie-2 overexpression model, we found that HEK293 cells lost the ability to effectively convert Tie-2 to sTie-2 (data not shown, refer to Figure 3C left lane in the upper panel), suggesting weak or absent expression of MT-MMPs relevant to sTie-2 production in HEK293 cells. Therefore, we compared MT-MMPs expressing in HEK293 cells with those expressing in HUVECs.
MMP-14 Is Involved in the Conversion of Tie-2 to sTie-2 in HUVECs
Through a screening of the gene expressions of MT-MMPs between HUVECs and HEK293 cells, MMP-14 was determined to be a potent candidate for Tie-2 shedding-related metalloproteinase. Briefly, reverse transcription-PCR demonstrated that MMP-15 and MMP-16 mRNAs, but not MMP-17 mRNA, were expressed in both cell types in a similar fashion. In contrast, MMP-14 was strongly expressed only in HUVECs (data not shown). To verify the relationship between MMP-14 and sTie-2 production, we tested the effect of MMP-14-knockdown on sTie-2 production in HUVECs. As shown in Figure 3B , sTie-2 production was markedly suppressed in HUVECs by either siRNA-MMP-14 to 1 or siRNA-MMP-14 to 2 treatment. To obtain more evidence of a relationship between MMP-14 and sTie-2 production, we constructed pcDNA3.1-active MMP-14 (aMMP-14) and pcDNA3.1-Tie-2, as described in the Methods section, and examined whether cotransfection with both the fTie-2 and active MMP-14 genes would induce sTie-2 production in HEK293 cells. As expected, sTie-2 was detected in the culture media from HEK293/MMP-14/fTie-2 ( Figure 3C, arrowhead) , in which the exogenous active MMP-14 mRNA expression was confirmed by reverse transcription-PCR ( Figure 3C , lower panels). Furthermore, the exogenous fTie-2 mRNA level was lower in HEK293/MMP-14/fTie-2 than in HEK293/luciferase/ fTie-2 ( Figure 3C , lower panels and right graph), suggesting that the production of sTie-2 was dependent on exogenous active MMP-14 in HEK293/MMP-14/fTie-2. Together, the findings in Figure 3 strongly indicate the involvement of MMP-14 in the conversion of fTie-2 to sTie-2.
PMA-Induced sTie-2 Production Is Dependent on MMP-14 in HUVECs
Next, we examined the relationship between PMA-induced sTie-2 production and MMP-14 in HUVECs. First, we confirmed that not only PMA stimulation but also MMP-14 knockdown did not affect the Tie-2 mRNA level in HUVECs (supplemental Figure 2 ). ELISA and Western blot analysis revealed that the PMA-induced sTie-2 production ( Figure 4A and B, respectively) was accompanied by the PMA-induced MMP-14 upregulation ( Figure 4C ), and was drastically suppressed in HUVECs with MMP-14 knockdown ( Figure 4A and B). Notably, consistent with the phenomena described in Figure 2 , the suppression of sTie-2 production by MMP-14 knockdown led to an increased level of cellular fTie-2, irrespective of PMA stimulation ( Figure 4C ), suggesting that MMP-14 activity is linked with the cellular fTie-2 level in HUVECs. Considering that MMP-14 is expressed on the cell surface as an active form produced by a furin-dependent processing of latent MMP-14, 26 the upregulation of MMP-14 by PMA is a possible molecular mechanism by which PMA enhanced sTie-2 production.
The PMA-Dependent Upregulation of MMP-14 mRNA and sTie-2 Production Is Mediated by the Protein Kinase C-Extracellular Signal-Regulated Kinase Signaling Pathways in HUVECs
Next, we further examined intracellular signaling molecules relevant to the PMA-dependent upregulation of MMP-14 mRNA and sTie-2 production in HUVECs. Consistent with a recent report, 24 the spontaneous production of sTie-2 was weakly but significantly suppressed in HUVECs treated with the p38 mitogen-activated protein kinase inhibitor ( Figure  5A ). However, in the present study, we discovered that the PMA-induced sTie-2 production was almost completely suppressed in HUVECs treated with the protein kinase C or the Figure 5A ), suggesting that the protein kinase C-extracellular signal-regulated kinase (ERK) signal is critical for the sTie-2 production in response to PMA. Interestingly, we obtained evidence indicating the critical involvement of these signals in the upregulation of MMP-14 mRNA in response to PMA ( Figure 5B ). These findings suggest that an autocrine linkage between endothelial MMP-14 and the cellular fTie-2 level is mediated by protein kinase C-ERK pathways.
TIMP-3 Upregulates the fTie-2 Level and Enhances the Effect of Ang-1 on Akt Activation and Subsequent Akt-Dependent Endothelial Functions in HUVECs
Next, we examined the effect of the endothelial MMP-14 -fTie-2 autocrine linkage on the Ang-1-dependent Tie-2 signaling pathways and endothelial functions in HUVECs. TIMP-3 treatment induced a significant increase in the cellular fTie-2 level in HUVECs compared with the level in the untreated controls, as did siRNA-MMP-14, leading to enhanced Ang-1-dependent activation of the PI3K-Akt, a representative Tie-2-associated signaling pathways ( Figure  6A and B) . Interestingly, the Ang-1-induced phosphorylation of ERK, one of the Tie-2-associated signaling pathways, was hardly affected by the treatment with TIMP-3 or siRNA-MMP-14 in confluent HUVECs (Figure 6A and B) . We also examined whether the endothelial MMP-14 -fTie-2 autocrine linkage-based modulation of Ang-1-dependent signaling pathways influenced the cellular functions that were depen-dent on the PI3K-Akt pathways. As shown in Figure 6C , TIMP-3 treatment enhanced the protective effect of Ang-1 on the serum starvation-induced reduction of cell viability in HUVECs. In addition, the suppressive effect of Ang-1 on Ang-2 expression, which is mediated by Ang-1-dependent activation of PI3K-Akt pathways, 27 was enhanced by TIMP-3 treatment ( Figure 6C ). By contrast, TIMP-3 treatment did not affect the endothelial migration induced by Ang-1 ( Figure  6C ). Finally, we examined the gene expression levels of TIMP-3 and MMP-14 in our animal model. The results of the real-time reverse transcription-PCR revealed a weak, but significant, downregulation of TIMP-3 mRNA and marked upregulation of MMP-14 mRNA in ischemic thigh muscle 1 day after the operation (supplemental Figure III) . These findings support the notion that TIMP-3 and MMP-14 are involved in the posttranscriptional regulation of Tie-2 in the early phase of ischemia-induced angiogenesis.
Discussion
Ang-Tie-2 system-related factors consist of an agonistic ligand, Ang-1; an antagonistic ligand, Ang-2; and the cognate receptor, Tie-2. Ang-1 is predominantly expressed in nonendothelial mesenchymal cells, such as pericytes, vascular smooth muscle cells, and fibroblasts, excluding inflammatory and hematopoietic stem cells; and the expression is thought to be relatively constant in pathophysiological settings. 9, 28 In contrast, both Tie-2 and Ang-2 are predominantly expressed in ECs, and the expression of the latter dramatically changes in a context-dependent manner. 10,28 -32 Ang-2 is highly expressed in an active angiogenic state but not in a quiescent state. 10, 30, 31 Therefore, at present, the Ang-Tie-2 system can be defined as Ang-2 level-dependent regulation of the spatial interaction between Ang-1 secreted from pericytes/vascular smooth muscle cells and Tie-2 in ECs in the vascular system. Generally, Ang-2-dependent attenuation of Tie-2 signals in ECs is thought to be a crucial event in angiogenic initiation/extension. In the present study, we examined Tie-2 expression in our animal model of hindlimb ischemia. The level of Tie-2 mRNA was gradually increased in the ischemic limbs in a timedependent manner. This phenomenon is similar to that in a previous report, 29 in which the authors suggested that Tie-2 is upregulated under pathophysiological conditions associated with angiogenesis. The increased level of Tie-2 probably promotes endothelial sprouting and subsequent vessel maturation. Interestingly, in the present study, we gained evidence of a transiently dissociated expression pattern between Tie-2 mRNA and fTie-2, which is probably due to posttranslational modification of the endothelial fTie-2 in the early phase of mouse limb ischemia. Although the significance of the dissociated expression pattern remains speculative, it may be that the phenomenon transiently induces attenuation of Tie-2-associated signals, thereby contributing to the switching between vessel stabilization and destabilization. Naturally, our in vivo findings are not sufficient to conclude that Tie-2 shedding is the mechanism underlying Tie-2 modification; thus, additional in vivo studies are under way in our laboratories. However, the in vivo phenomenon is attractive and suggests the possibility of a novel regulatory system for Tie-2 signaling pathways.
Through in vitro studies, we identified a potent mechanism to account for the previously described in vivo phenomenon (ie, autocrine linkage between MMP-14 and the level of fTie-2 in ECs). Numerous recent reports [33] [34] [35] have established that endothelial MMP-14 plays a critical role in angiogenesis, especially in the initiation and proliferation/extension phases, based on direct and indirect activities for extracellular matrix degradation. In the present study, we found that another possible role of endothelial MMP-14 in angiogenesis as a shedder of the ectodomain of Tie-2, not only for releasing sTie-2 but also for leading to a reduced endothelial fTie-2 level. Considering these biological functions of MMP-14, vascular destabilization and subsequent endothelial migration/sprouting may be linked via MMP-14 activity in ECs; this coupled mechanism seems to be reasonable in angiogenic systems. Together, our in vivo data (Figure 1 and supplemental Figure III ) may reflect the autocrine interaction between MMP-14 activity and Tie-2 shedding in ECs; this interaction may cause sufficient attenuation of Tie-2 signaling pathways and subsequent transient vessel destabilization to initiate angiogenesis jointly with Ang-2.
In the present study, we also identified the suppressors for Tie-2 shedding: TIMP-2 and TIMP-3. The TIMP family is generally known to be a negative regulator for angiogenesis, and the negative function is exerted via inhibition of metalloproteinase activity. 25 TIMP-2 and TIMP-3 effectively suppress MMP-14 activity 25 ; thus, these factors might control not only MMP-14 -dependent degradation of the extracellular matrix but also the cellular fTie-2 level in ECs, and they might regulate vessel stabilization/destabilization during angiogenesis. A recent study 39 supported this hypothesis; the researchers demonstrated that endothelial TIMP-2 and pericyte TIMP-3 coregulated vessel stabilization. In that report, the researchers focused their attention on the suppressive effects of TIMP-2 and TIMP-3 on metalloproteinase-mediated extracellular matrix degradation as the mechanism underlying TIMP-2-and TIMP-3-induced vessel stabilization. In the present study, however, our data suggest the possible existence of another molecular mechanism. The in vitro evidence shown in Figure 6 demonstrates that the suppression of Tie-2 shedding by TIMP-3 or MMP-14 knockdown augmented cellular fTie-2, by which Ang-1-dependent activation of the PI3K-Akt pathways was enhanced. Therefore, TIMP-2 and TIMP-3 may contribute not only to the inactive endothelial migration but also to vessel stabilization, by acting on endothelial MMP-14. In the experiment shown in Figure 6 , we used TIMP-3 but not TIMP-2 to suppress Tie-2 shedding, because TIMP-3 is expressed in a cell type-specific manner. In a previous report, 36 TIMP-3 was shown to be predominantly expressed in mural cells in vascular systems during fetal development. Consistent with this finding, our screening of TIMP-3 
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Involvement of MMP-14 in Tie-2 Shedding expression in various cell types revealed that the expression of TIMP-3 mRNA was clearly higher in nonendothelial mesenchymal cells than in ECs in vitro (supplemental Figure IV) . From these findings, we hypothesized the possibility of a spatial interaction between TIMP-3 from pericytes and endothelial MMP-14 (supplemental Figure  V) . Briefly, the suppression of the endothelial Tie-2 shedding by TIMP-3 from pericytes leads to stably promoting Tie-2 signaling in ECs via Ang-1 from pericytes in the quiescent vessels. In contrast, the context-dependent increase in MMP-14 activity leads to a Tie-2 sheddingmediated decrease in the endothelial fTie-2 level, resulting in the induction vessel destabilization and subsequent endothelial migration. The evidence in Figure 6 partially supports this hypothesis. Attempts to validate the hypothesis in vivo are under way in our laboratory, and we anticipate that novel angiogenic mechanisms will come evolve in the future.
Regarding the active balance between PI3K-Akt and ERK in ECs, a recent study 37 demonstrated that the Ang-1-Tie-2 complex aggregated at cell-cell contacts and preferentially activated PI3K-Akt rather than ERK. A preponderance of PI3K-Akt activation relative to ERK may be necessary for quiescent ECs, as supported by a recent report 38 using Akt-1-knockout mice. In the present study, an Ang-1-dependent increase in the activation of the PI3K-Akt, but not of the ERK, pathway was observed in confluent HUVECs treated with TIMP-3 or siRNA-MMP-14. Interestingly, the phenomenon did not occur in sparse HUVECs (data not shown). These findings suggest that Ang-1-dependent ERK activation is limited in ECs with sufficient cell-to-cell contact. The mechanism underlying this phenomenon is unclear, but endothelial behavior in response to Ang-1 seems to be modified by both changes in cell-to-cell/matrix contact and changes in the level of endothelial fTie-2, which would control the dual functions of Ang-1 (an inducer of endothelial migration and an endothelial stabilizer). Figure 6 . Suppression of Tie-2 shedding modifies the Ang-1-dependent Tie-2 signaling pathways and endothelial functions in HUVECs. A and B, After transfection of either siRNA-MMP-14 to 1 or siRNA-control 1 (siRNA control) (A) into HUVECs, or after the treatment of HUVECs with TIMP-3 (B), the cells were cultured under normal conditions until reaching confluence. Then, the culture medium (CM) was replaced with serum-free medium with or without Ang-1, 500 ng/mL. Fifteen minutes after stimulation with Ang-1, the cells were harvested and subjected to Western blot analysis (WB) for the indicated factors. Representative results of WB are shown (A and B, left panels). The band intensity was measured, and the expression levels of fTie-2, p-Akt, and p-ERK were normalized with those of ␤-actin, total Akt, and total ERK, respectively, and expressed as the relative fold increase compared with that in untreated controls (A and B, right panels; *PϽ0.0005 and **PϽ0.01 [nϭ3 each]). C, Effect of TIMP-3 on Ang-1-promoted protection of cell viability (left graphs, nϭ6) and migratory activity (middle graphs, nϭ3), and on Ang-1-dependent downregulation of Ang-2 (right graphs, nϭ3). Details of the experimental procedures are described in the "Methods" section (*PϽ0.0005, **PϽ0.01, and #PϽ0.0001). The dotted line in the left graph shows the mean relative number of viable cells counted just before inducing cell death under serum starvation.
In conclusion, we demonstrated that endothelial MMP-14 was implicated in the production of an sTie-2 of approximately 75 kDa, and was involved in regulating the cellular fTie-2 level in ECs. In addition, the endothelial MMP-14 activity was shown to modulate Ang-1-dependent Tie-2-associated signal pathways and functions. These findings suggest that MMP-14 -induced Tie-2 shedding is a novel regulatory mechanism for the Ang-Tie-2 system. The evidence presented herein might well provide novel insights into the functions of the vascular system in a number of pathophysiological settings.
